Chugai Pharmaceutical Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Chugai Pharmaceutical and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 7604 Chugai Pharmaceutical employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Chugai Pharmaceutical has purchased the following applications: Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2014, IDBS E-WorkBook for Content Management in 2016, Ptengine Insight for Marketing Analytics in 2022 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Chugai Pharmaceutical is running and its propensity to invest more and deepen its relationship with Microsoft , Amazon Web Services (AWS) , IDBS or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Chugai Pharmaceutical revenues, which have grown to $7.13 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Chugai Pharmaceutical intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.